Valuation: Proteome Sciences plc

Market Cap 6.31M 8.5M 7.39M 6.88M 11.92M 811M 12.11M 81.05M 31.81M 404M 31.92M 31.21M 1.35B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 21.3M 28.67M 24.93M 23.2M 40.23M 2.74B 40.85M 273M 107M 1.36B 108M 105M 4.57B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 month+9.09%
3 months+20.00%
6 months-2.17%
Current year-28.00%
1 week 1.54
Extreme 1.545
2.13
1 month 1.3
Extreme 1.3
2.3
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
17.66
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
6/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-40.79%-75.92% 8.5M
+0.09%+2.56%-16.24%-5.06% 183B
-0.37%+2.62%-5.37%-2.70% 109B
-0.29%+0.47%+8.83%+66.58% 60.57B
+3.50%+0.47%+28.65%+49.27% 51.8B
+0.10%+5.92%-7.09%-40.56% 45.64B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+3.32%-33.00% 31.49B
+0.40%+3.89%+42.51%-7.36% 24B
-1.22%+6.69%+0.84%+1.26% 22.26B
Average +1.46%+4.37%+1.63%-5.28% 56.12B
Weighted average by Cap. +0.92%+3.49%-1.36%+4.41%

Financials

2024 2025
Net sales 4.89M 6.58M 5.72M 5.32M 9.23M 628M 9.37M 62.74M 24.62M 313M 24.71M 24.16M 1.05B 3.76M 5.06M 4.4M 4.09M 7.09M 483M 7.2M 48.22M 18.93M 240M 18.99M 18.57M 806M
Net income -3.41M -4.58M -3.99M -3.71M -6.43M -438M -6.53M -43.73M -17.16M -218M -17.22M -16.84M -731M -3.06M -4.12M -3.58M -3.33M -5.78M -393M -5.87M -39.3M -15.42M -196M -15.47M -15.13M -657M
Net Debt 13.39M 18.03M 15.67M 14.59M 25.29M 1.72B 25.69M 172M 67.49M 857M 67.71M 66.23M 2.87B 14.99M 20.18M 17.54M 16.33M 28.31M 1.93B 28.74M 192M 75.53M 959M 75.78M 74.11M 3.22B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
31/07/26 GBX 1.800 -.--% 0
30/07/26 GBX 1.800 -.--% 1,000
29/07/26 GBX 1.800 -.--% 1,880
28/07/26 GBX 1.800 -5.26% 306,081
27/07/26 GBX 1.900 +5.56% 25,524